T501-1261 Screening compound: 4-(1,3-benzothiazol-2-yl)-1-(3-{[4-(cyclopropylmethyl)-4H-1,2,4-triazol-3-yl]methyl}piperidin-1-yl)butan-1-one

T501-1261 Screening compound: 4-(1,3-benzothiazol-2-yl)-1-(3-{[4-(cyclopropylmethyl)-4H-1,2,4-triazol-3-yl]methyl}piperidin-1-yl)butan-1-one
T501-1261 Screening compound: 4-(1,3-benzothiazol-2-yl)-1-(3-{[4-(cyclopropylmethyl)-4H-1,2,4-triazol-3-yl]methyl}piperidin-1-yl)butan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound T501-1261
4-(1,3-benzothiazol-2-yl)-1-(3-{[4-(cyclopropylmethyl)-4H-1,2,4-triazol-3-yl]methyl}piperidin-1-yl)butan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T501-1261

Molecular Formula

C23H29N5OS (C23 H29 N5 OS)

Compound Name

4-(1,3-benzothiazol-2-yl)-1-(3-{[4-(cyclopropylmethyl)-4H-1,2,4-triazol-3-yl]methyl}piperidin-1-yl)butan-1-one

IUPAC name

4-(13-benzothiazol-2-yl)-1-(3-{[4-(cyclopropylmethyl)-4H-124-triazol-3-yl]methyl}piperidin-1-yl)butan-1-one

SMILES

O=C(CCCc1nc(cccc2)c2s1)N1CC(Cc2nncn2CC2CC2)CCC1

InChI

InChI=1S/C23H29N5OS/c29-23(9-3-8-22-25-19-6-1-2-7-20(19)30-22)27-12-4-5-18(15-27)13-21-26-24-16-28(21)14-17-10-11-17/h1-2,6-7,16-18H,3-5,8-15H2/t18-/m1/s1

InChI Key

IJBASGQLHCLGFY-GOSISDBHSA-N

MDL Number (MFCD)

MFCD31986758

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

423.58

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.488

Distribution Coefficient, logD

3.488

Water Solubility, LogSw

-3.78

Polar Surface Area

52.093

Acid Dissociation Constant (pKa)

21.08

Base Dissociation Constant (pKb)

2.84

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

56.52

T501-1261 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Lipid Metabolism Library (9174 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cardiovascular
  • Metabolic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with T501-1261 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound T501-1261?
Check Price and Availability of T501-1261, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of T501-1261 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for T501-1261
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for T501-1261
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of T501-1261 available by request